0001104659-21-130370.txt : 20211027 0001104659-21-130370.hdr.sgml : 20211027 20211027124630 ACCESSION NUMBER: 0001104659-21-130370 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211027 DATE AS OF CHANGE: 20211027 EFFECTIVENESS DATE: 20211027 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cyprium Therapeutics, Inc. CENTRAL INDEX KEY: 0001890689 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-418723 FILM NUMBER: 211351915 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 D 1 primary_doc.xml X0708 D LIVE 0001890689 Cyprium Therapeutics, Inc. 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY NEW YORK 10014 781-652-4500 DELAWARE None None Corporation true Lung Yam 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Executive Officer Lindsay A. Rosenwald 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Director Other Health Care No Revenues 06b false 2020-07-27 false true false 25000 National Securities Corporation 7569 None None 20 VESEY STREET, 25TH FLOOR NEW YORK NY NEW YORK 10281 All States false 7000000 7000000 0 false 75 870000 0 0 false Cyprium Therapeutics, Inc. /s/ Lung S. Yam, M.D., Ph.D. /s/ Lung S. Yam, M.D., Ph.D. Chief Executive Officer 2021-10-05